Institucional
Institucional
Missão e Visão ALAT
Estatutos e regulamentos
Comitê Executivo
Fundación Inspira
Comunicación ALAT
Atividades ALAT
Sociedades Nacionais
FIRS
FOLASOR
Certificados
Departamentos
Asma
Circulación pulmonar
Cirugía torácica
Cuidados Respiratorios
Endoscopia respiratoria y neumología intervencionista
Enfermedades infecciosas
Enfermedades intersticiales
EPOC
Fisiopatología
Imágenes
Medicina crítica
Oncología torácica
Pediatría
Sueño
Tabaquismo y medio ambiente
Trasplante Pulmonar
Tuberculosis
Cursos ALAT
Congressos
Congreso 2026
Nuevo
Información
Congreso 2025
Información
Inscripciones
Alojamiento
Trabajos Libres
Meios
Educativos
Publicaciones
Biblioteca
Neumoteca
Podcasts
Nuevo
Guías ALAT
Becas y Cursos
MECOR
Espirometría Itinerante ALAT
Becas
ALAT Joven
Estudios
PLATINO
Actualización
Eventos
Contacto
Registrarme
Ingresar
Biblioteca
Tratamientos
Inicio
Categorías
Temas
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
Tratamientos
Tema:
COVID-19
On the use of corticosteroids for 2019-nCoV pneumonia
Tratamientos
Tema:
COVID-19
Convalescent Plasma to Treat COVID-19
Tratamientos
Tema:
COVID-19
Recent discovery and development of inhibitors targeting coronaviruses
Tratamientos
Tema:
COVID-19
Drug treatment options for the 2019-new coronavirus (2019- nCoV)
Tratamientos
Tema:
COVID-19
Effective Treatment of Severe COVID-19 Patients with Tocilizumab
Tratamientos
Tema:
COVID-19
The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options
Tratamientos
Tema:
COVID-19
The convalescent sera option for containing COVID-19
Tratamientos
Tema:
COVID-19
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Tratamientos
Tema:
COVID-19
Of chloroquine and COVID-19
Tratamientos
Tema:
COVID-19
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Tratamientos
Tema:
COVID-19
Harnessing the immune system via FcγR function in immune therapy A pathway to next- gen mAbs
Tratamientos
Tema:
COVID-19
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Tratamientos
Tema:
COVID-19
Reducing mortality from 2019-nCoV host-directed therapies should be an option
Tratamientos
Tema:
COVID-19
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
Tratamientos
Tema:
COVID-19
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Tratamientos
Tema:
COVID-19
Hydroxychloroquine and azithromycin as a treatment of COVID-19
Tratamientos
Tema:
COVID-19
Clinical trials on drug repositioning for COVID-19 treatment
Tratamientos
Tema:
COVID-19
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Tratamientos
Tema:
COVID-19
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Tratamientos
Tema:
COVID-19
Anterior
Siguiente
1
2
Mostrando
21
a
40
de
40
resultados
Institucional
Missão e Visão ALAT
Comitê Executivo
Estatutos e regulamentos
Atividades ALAT
Sociedades Nacionais
Membros
Beneficios
Hacerme miembro
Meios
Publicaciones
Biblioteca
Contáctenos
Contacto
